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Abstract
Mucosa-associated lymphoid tissue 1 (MALT1) controls antigen receptor–mediated signalling to nuclear factor kB (NF-kB)
through both its adaptor and protease function. Upon antigen stimulation, MALT1 forms a complex with BCL10 and
CARMA1, which is essential for initial IkBa phosphorylation and NF-kB nuclear translocation. Parallel induction of MALT1
protease activity serves to inactivate negative regulators of NF-kB signalling, such as A20 and RELB. Here we demonstrate a
key role for auto-proteolytic MALT1 cleavage in B- and T-cell receptor signalling. MALT1 cleavage occurred after Arginine
149, between the N-terminal death domain and the first immunoglobulin-like region, and did not affect its proteolytic
activity. Jurkat T cells expressing an un-cleavable MALT1-R149A mutant showed unaltered initial IkBa phosphorylation and
normal nuclear accumulation of NF-kB subunits. Nevertheless, MALT1 cleavage was required for optimal activation of NF-kB
reporter genes and expression of the NF-kB targets IL-2 and CSF2. Transcriptome analysis confirmed that MALT1 cleavage
after R149 was required to induce NF-kB transcriptional activity in Jurkat T cells. Collectively, these data demonstrate that
auto-proteolytic MALT1 cleavage controls antigen receptor-induced expression of NF-kB target genes downstream of
nuclear NF-kB accumulation.
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Introduction
The MALT1 gene was identified from a recurrent chromosomal
translocation in mucosa–associated lymphoid tissue (MALT)
lymphoma [1]. The t(11;18)(q21;q21) breakpoint generates an
oncogenic API2-MALT1 fusion protein that constitutively acti-
vates NF-kB in cell lines [2,3], in MALT lymphomas [4] and in
transgenic mice [5]. Two other chromosomal translocations,
t(1;14)(p22;q32) and t(14;18)(q32;q21), are also associated with
MALT lymphoma and result in IgH enhancer-driven overexpres-
sion of BCL10 and MALT1 respectively [6–9]. Their oncogenic
activity is linked to the involvement of the CARMA1-BCL10-
MALT1 (CBM) complex in antigen receptor-mediated activation
of the transcription factor NF-kB, which controls the expression of
numerous anti-apoptotic and proliferation-promoting genes [10].
Genetic and biochemical studies have shown that MALT1 and
its binding partner BCL10 act downstream of the scaffold protein
CARMA1 (also known as CARD11) as key mediators of canonical
NF-kB activation upon antigen receptor stimulation. Mice
deficient for Bcl10 [11], Malt1 [12,13] or Carma1 [14–17] display
severely impaired T cell receptor (TCR) and B cell receptor (BCR)
responses. Antigen triggering of T- and B-cells activates a cascade
of tyrosine phosphorylation events that converge at the activation
of Ser/Thr kinases such as PKCh and PKCb, respectively.
Activated PKCh/b (and most likely additional kinases) phosphor-
ylate CARMA1, inducing a conformational change that exposes
its coiled coil and CARD motifs [18,19]. These events are thought
to take place in lipid rafts, which are sphingolipid- and cholesterol-
rich micro-domains in the cell membrane [20]. The phosphory-
lation-induced conformational change of CARMA1 allows the
recruitment of additional CARMA1 molecules [18], BCL10
[19,21,22] and MALT1 [23] and most likely triggers the initiation
of oligomeric active signaling complexes [24]. It is thought that the
formation of CBM oligomers in turn induces the recruitment,
oligomerization and activation of the E3-ubiquitin ligase activity of
TRAF6, resulting in Lys63-linked poly-ubiquitination of MALT1
[25], BCL10 [26] as well as the ligase itself [27]. These poly-
ubiquitin chains assist CARMA1-dependent recruitment of the
IkB kinase (IKK) complex via the ubiquitin-binding domain of the
IKKc subunit [28], which then culminates in full IKK activation
via poly-ubiquitination of IKKc [29]. Activated IKK phosphor-
ylates the NF-kB inhibitory protein IkB, which marks it for
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degradation by the proteasome, thereby releasing NF-kB com-
plexes and allowing their nuclear translocation.
MALT1 controls T- and B-cell activation not only through its
adaptor function but also via its proteolytic activity [30,31]. TCR
stimulation induces MALT1-mediated cleavage and inactivation
of the NF-kB inhibitor A20, resulting in a stronger NF-kB
response and increased IL-2 production [30]. Moreover, MALT1-
dependent cleavage of RELB, an NF-kB family member that acts
as a negative regulator of T-cell activation [32], promotes NF-kB
activation in an IKK-independent manner [33]. To date four
additional MALT1 substrates have been identified: BCL10,
CYLD, MCPIP-1 (also known as Regnase-1) and NIK. Cleavage
of MALT1’s binding partner BCL10 does not control NF-kB
activity but is thought to affect integrin-mediated T-cell adhesion
[31]. Cleavage of CYLD, a de-ubiquitinating enzyme and known
negative regulator of NF-kB signaling, was shown to be essential
for TCR-induced JNK activation [34]. MCPIP-1 is an RNAse
that destabilizes mRNAs of T cell effector genes; its cleavage by
MALT1 leads to stabilization of TCR-induced gene transcripts
[35]. Finally, cleavage of NIK by the API2-MALT1 fusion protein
activates non-canonical NF-kB signaling, which contributes
together with canonical NF-kB activation to MALT lymphoma-
genesis [36]. MALT1 protease activity is also essential for the
survival of cells derived from the activated B-cell subtype of diffuse
large B-cell lymphoma (ABC-DLBCL) [37,38], which are addicted
to constant MALT1-driven NF-kB signaling [39].
The MALT1 protein was originally referred to as a ‘para-
caspase’ because it contains a caspase p20-like proteolytic domain
preceded by a large pro-domain, consisting of a Death Domain
(DD) and two immunoglobulin-like (Ig) domains [3]. As such,
MALT1 structurally resembles initiator caspases. These have
longer pro-domains and become catalytically active upon prox-
imity-induced dimerization. Subsequent auto-proteolysis of the
protease domain into p10 and p20 subunits is thought to stabilize
activated caspase dimers [40]. Oligomerization of the CBM
complex in the lipid raft environment after antigen-receptor
triggering is thought to promote MALT1 proteolytic activity by
induced proximity, similar to initiator caspases. However, the
mechanisms required to stabilize the active form of MALT1 seem
to be fundamentally different from initiator caspases. Indeed,
catalytically active MALT1 dimers are stabilized by mono-
ubiquitination of MALT1 on lysine 644 in its C-terminal region
following the protease domain [41,42]. Whether MALT1, like
initiator caspases, is also a target of its own proteolytic activity, and
if such an auto-proteolysis event could contribute to NF-kB
signalling, is unknown. Here, we demonstrate that MALT1 is a
substrate of its own protease activity and that MALT1 auto-
proteolysis is an essential step in antigen receptor-induced NF-kB-
dependent gene transcription.
Results
Targeting MALT1 to the plasma membrane in 293T cells
induces its cleavage into 19 and 76 kDa fragments
T or B cell receptor stimulation induces CARMA1-mediated
recruitment of BCL10 and MALT1 to the lipid raft membrane
fractions, which is essential for NF-kB activation [14,22,43]. To
test whether lipid raft targeting promotes MALT1 activation, we
generated a fusion of MALT1 to the N-terminal myristoylation-
palmitoylation signal sequence of Lck (mp-MALT1, Figure 1A),
which can target proteins into glycosphingolipid-enriched mem-
branes [44]. When ectopically expressed in 293T cells, this
construct was highly active, while MALT1 alone was unable to
activate an NF-kB reporter ([45] and Figure 1B). We demonstrat-
ed previously through subcellular fractionation via sucrose density
gradient centrifugation that ectopic MALT1 in 293T cells is
merely cytosolic [5]. Subcellular fractionation of mp-MALT1
showed that it, as expected, also resides in the detergent resistant
membrane (DRM) fractions, the latter marked by the presence of
the kinase Lck (Figure 1C, lane 4 and 5). With the MALT1
antibody used (MALT1-N), which recognizes the N-terminus of
MALT1, we further detected a 19 kDa fragment (p19) in the
DRM fractions, (Figure 1C, lane 4–5). This N-terminal p19
fragment was also detectable in lysates of 293T cells expressing
mp-MALT1, though not in lysates of cells expressing wild-type
MALT1 (Figure 1D, lane 1–2). Expression of a catalytically
inactive form of MALT1 (mp-MALT1-C464A) failed to generate
the p19 fragment (Figure 1D, lane 3), suggesting that MALT1
protease activity is required for the generation of this N-terminal
fragment.
MALT1 protease has specificity for an arginine (R) residue in
the substrate P1 position [30,31,46]. Mutating candidate cleavage
sites in mp-MALT1 showed that an R149A mutant was resistant
to cleavage, similar to the C464A mutant (Figure 1D, lane 3-4),
while normal cleavage occurred for an R191A mutant (Figure S1
A, lane 4). Like mp-MALT1, the R149A mutant cleaved known
MALT1 substrates A20 and CYLD with comparable efficiency in
293T cells and had normal enzymatic activity in a cellular YFP-
LVSR-CFP reporter cleavage assay (Figure S1 B and C). Co-
expression of the R149A mutant of mp-MALT1 with the C464A
mutant restored p19 formation again (Figure 1D, lane 5). This
indicates that the catalytic activity of the R149A mutant can
mediate - directly or indirectly - the cleavage of the inactive
C464A mutant of mp-MALT1 after R149.
Western blotting with an antibody directed against the MALT1
C-terminus identified a 76 kDa fragment (p76) for mp-MALT1,
which was absent for the R149A and C464A mutants (Figure 1E,
top). This finding is consistent with cleavage of mp-MALT1 (95
kDa) into two fragments of 19 and 76 kDa, respectively. The p76
fragment generated from mp-MALT1 was also detected with an
antibody raised against the p76 neo-epitope (Figure 1E, bottom,
lane 2). A ubiquitin-p76 fusion protein, which is efficiently
processed by ubiquitin-specific proteases in the cell into free
ubiquitin and the p76 neo-epitope fragment, served as a positive
control for p76 generation (Figure 1A and 1E, lane 1). Taken
together, these data suggest that targeting of mp-MALT1 to
DRMs induces its protease activity, and that MALT1 activity is
required for its cleavage at R149 in the pro-domain.
BCL10 induces cleavage of MALT1 at R149 in 293T cells
Lucas et al. [2] reported that co-expression of BCL10 resulted in
strong MALT1 oligomerization and activation of an NF-kB
reporter in 293T cells [2]. We and others had demonstrated that
co-expression of BCL10 with MALT1 in 293T cells triggers
MALT1 protease activity and cleavage of its substrates A20 and
BCL10 [30,31]. When co-expressing BCL10 and MALT1 in
293T cells, we again observed the appearance of the p19 N-
terminal cleavage fragment of MALT1 (Figure 2A, lane 3), in
addition to a previously described hyper-phosphorylation of
BCL10 [30,31]. Processing did not occur when BCL10 was co-
expressed with the C464A or the R149A mutant of MALT1
separately (Figure 2B). However, formation of the p19 fragment
was restored when the R149A and C464A mutants were co-
expressed together with BCL10, indicating that in this experi-
mental setting, BCL10 triggers the protease activity of the
MALT1-R149A mutant that induces – directly or indirectly -
the cleavage of the MALT1-C464A mutant at R149 (Figure 2B).
MALT1 Auto-Proteolysis Triggers NF-kB Activation
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MALT1 undergoes auto-proteolysis in vitro
Thus far MALT1 cleavage was observed in cellular assays,
which do not discriminate between a direct, auto-proteolytic event
and an indirect cleavage event, which could be mediated by a
protease that is activated by MALT1-mediated processing. To test
the possibility of MALT1 auto-proteolysis we therefore performed
in vitro cleavage assays. The recombinant MALT1 we used
represents the full length MALT1 with the Flag-epitope and the
StrepII-tag at its N terminus (F-STII-MALT1, Figure 3A). This
construct was purified from stably transduced HKB11 cells via
Strep-Tactin affinity chromatography. The in vitro proteolytic
activity of F-STII–MALT1 was assessed by incubation with the
fluorogenic tetrapeptide substrate Ac-LVSR-AMC in paracaspase
assay buffer [33]. Increasing concentrations of the cosmotropic salt
NH4-citrate gradually increased MALT1 cleavage activity and
release of free AMC, which could be completely blocked by the
MALT1 tetrapeptide inhibitors z-VRPR-fmk and z-LVSR-fmk
(Figure 3B, top). Immunoblots of the in vitro reactions further
demonstrated generation of the p76 and p19 cleavage fragments of
MALT1 with an efficiency that mimicked the pattern of MALT1
protease activity observed in the LVSR-AMC protease assay
(Figure 3B and S3, bottom).
To further assess MALT1 auto-proteolysis, we generated
recombinant forms of MALT1 (aa 2-824) fused to a leucine
zipper dimerization motif (LZ-MALT1 and LZ-MALT-C464A)
(Figure 3A), which promotes dimerization-dependent MALT1ac-
tivation [47]. Processing of Ac-LVSR-AMC by LZ-MALT1 in the
presence of 0.8 M NH4-citrate was 3 fold higher than for F-STII-
Figure 1. Targeting mp-MALT1 to DRMs induces its proteolysis at R149 in 293T cells. A) Features of mp-MALT1 (mp: myristoylation-
palmitoylation sequence) and Ub-p76 (Ubiquitin-p76 fusion protein). R149: MALT1 cleavage site. Flag: Flag epitope, DD: Death Domain, Ig:
immunoglobulin-like domain, p20: caspase p20-like domain, C464: MALT1 catalytic cysteine, T6-Ig and T6-C: TRAF6 binding site in second Ig domain
and C-terminus, respectively. Ub: Ubiquitin. B) NF-kB-reporter assays of 293T cells transiently expressing wild-type MALT1, mp-MALT1 or empty
vector (mock). NF-kB-dependent luciferase activity is shown as fold induction of vector-transfected cells and represents the mean +/- S.D. of at least
three independent experiments (n = 3). Cell lysates were immunoblotted with a-Flag, a non-specific band was used as loading control (LC). C) Lysates
of 293T cells transiently transfected with mp-MALT1 were subjected to sucrose density gradient centrifugation and aliquots of the serial fractions
(1-12 from top to bottom) were immunoblotted with a-MALT1-N, a-Lck, a kinase residing in the Detergent Resistant Membrane (DRM) fractions, and
a-GAPDH, a cytosolic marker. D-E) Immunoblot of lysates of 293T cells transiently expressing wild-type MALT1, mp-MALT1 and its mutants or
Ubiquitin-p76 as specified with indicated antibodies. eMALT1: endogenous MALT1. b-actin (D) and LC: non-specific band (E) are loading controls.
Arrows (panel C, D, E)) indicate the N-terminal p19 or the C-terminal p76 cleavage fragment respectively. All molecular mass standards are in kDa.
doi:10.1371/journal.pone.0103774.g001
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MALT1, whereas a corresponding LZ-MALT1-C464A construct
was inactive (Figure 3B, top). Immunoblots of the in vitro cleavage
reactions again showed the generation of the expected N-terminal
fragment of 24 kDa (matching the p19 fragment) and the C-
terminal p76 fragment for LZ-MALT1 though not for its C464A
mutant (Figure 3B, bottom). Collectively these data indicate that
MALT1 is able to cleave itself at R149.
The MALT1 p76 cleavage fragment activates NF-kB
signalling
To investigate whether auto-processing of MALT1 has a role in
NF-kB signalling, we first tested the capacity of the p19 and p76
fragments of MALT1 to promote NF-kB activation. Like full
length MALT1 alone, expression of the p19 fragment (MALT1-
p19, Figure 4A) did not activate a NF-kB reporter in 293T cells
(Figure 4B). In contrast, the p76 fragment potently activated the
NF-kB reporter despite the fact that it has lost the ability to bind
BCL10 (Figure 4C). This suggests that removal of the N-terminal
part of MALT1 might promote its capacity to activate NF-kB in a
BCL10-independent manner. NF-kB activation by MALT1
involves TRAF6 binding via two distinct binding sites [27,45]
located within the Ig2 domain (T6-Ig) and at the MALT1 C-
terminus (T6-C), respectively, and both are present in the p76
cleavage fragment (Figure 4A). Mutation of either one of the two
TRAF6 binding sites, E313A/E316A (T6Ig-m) or E806A (T6C-
m), strongly impaired the potential of p76 to activate NF-kB
signalling in 293T cells (Figure 4C). Steptavidin pull-down
experiments with Avi-tagged p76 constructs (bio-IP) confirmed
that each of these individual mutations severely weakened the
p76/TRAF6 interaction, while a complete inhibition of TRAF6
binding required mutation of both sites (T6Ig/C-m) (Figure 4C,
bottom). Thus, p76-mediated NF-kB activation was clearly
TRAF6-dependent. A shorter MALT1-C construct comprising
only AA 334 to 824, which retained efficient TRAF6 binding via
the T6C binding site, was unable to activate NF-kB signalling,
suggesting an additional requirement for the intact Ig1 and Ig2
domains (Figure 4, A and C). Collectively, these data suggest that
the MALT1 p76 fragment promotes NF-kB activation in a
TRAF6-dependent but BCL10-independent manner.
Activation of NF-kB signalling downstream of MALT1 involves
the E3 ubiquitin ligase activity of TRAF6, which is activated upon
TRAF6 oligomerization [27]. Analysis of the structure of the
tandem Ig1–Ig2 domains of MALT1 by crystallography and size
exclusion chromatography has suggested their potential to form
tetramers [48]. However, no oligomerization has been observed
when full-length MALT1 proteins were expressed by themselves
[2], suggesting that the N-terminal DD domain of MALT1 might
prevent oligomerization. Bio-IP experiments with Avi-tagged p76
indeed showed an interaction with Flag-tagged p76, but not with
Figure 2. BCL10 mediates cleavage of MALT1 at R149 in 293T
cells. A) Immunoblot of lysates of 293T cells transiently expressing
MALT1 alone or in combination with BCL10 with antibodies against
MALT1 [31], BCL10 and tubulin. B) Immunoblot of streptavidin pull-
downs (bio-IPs) of Avi-tagged MALT1 and its mutants co-expressed with
BCL10 in 293T cells as specified. AS: a-specific band. Arrows indicate the
N-terminal p19 cleavage fragment. All molecular mass standards are in
kDa.
doi:10.1371/journal.pone.0103774.g002
Figure 3. MALT1 undergoes auto-proteolysis in vitro. A) Features
of F-STII-MALT1 and LZ-MALT1. F: Flag epitope, STII: StrepII-tag, 6H: 6-
Histidine tag, LZ: Leuzine zipper. B) Top: In vitro cleavage of the
fluorogenic tetratpeptide substrate Ac-LVSR-AMC (50 mM) by F-STII-
MALT1 in increasing concentrations of the cosmotropic salt NH4-citrate
(0.2, 0.4, 0.6, and 0.8 M), by F-STII-MALT1 in 0.8M NH4-citrate buffer in
the presence of the MALT1 protease inhibitors z-VRPR-fmk (10 mM) and
z-LVSR-fmk (10 mM) and by LZ-MALT1 or LZ-MALT1-C464A in 0.8 M
NH4-citrate buffer. The barchart shows cleavage activity as Fluorescence
Units (FU) increase/min. Results are expressed as means 6 SD (n = 3).
Bottom: enzymatic reactions were analysed by immunoblotting with a-
MALT1-C, a-p76 neo-epitope and a-MALT1-N.
doi:10.1371/journal.pone.0103774.g003
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full-length MALT1 (Figure 4D). Auto-proteolytic removal of the
DD domain of MALT1 might thus facilitate oligomerization of
p76 and the associated TRAF6 molecules, thereby inducing the
E3 ubiquitin ligase activity of the latter required for downstream
signalling.
MALT1 is cleaved in stimulated B cells and in ABC-DLBCL
cells
Next we investigated the occurrence of MALT1 proteolysis in
cell lines derived from DLBCL. The activated B-cell (ABC)-
subtype of DLBCL is addicted to NF-kB signalling [49] and has
constant MALT1 protease activity [37,38]. Consequently, cell
lines derived from such lymphomas, such as HBL-1 and OCI-Ly3,
show a constitutive presence of cleaved BCL10 that can be
detected with an antibody specifically recognizing the processed
form of this protein [38] (Figure 5A). Likewise, the MALT1 p19
fragment was detected in lysates of these cells, and both MALT1
and BCL10 cleavage could be prevented by treating the cells with
the MALT1 protease inhibitor z-VRPR-fmk (Figure 5A). In
contrast, no MALT1 processing was detectable in the B cell
lymphoma cell line BJAB, which is derived from the germinal
center B-cell (GCB) subtype of DLBCL and has no steady MALT1
protease activity (Figure 5B). MALT1 processing was also
undetectable in the EBV-transformed B-cell line Raji (Figure 5C).
However, stimulation of these cells with PMA and ionomycin (P/I)
induced MALT1 protease activity and the appearance of cleaved
BCL10 and the MALT1 p19 fragment, which again could be
blocked by addition of z-VRPR-fmk (Figure 5, B and C).
The marginal zone B cell lymphoma cell line SSK41 has an
amplification of the MALT1 locus [8] that drives its overexpres-
sion and has constant MALT1 protease activity. As a conse-
quence, SSK41 cells constantly cleave MALT1 substrates A20
[30] and CYLD ([34] and Figure 5D, lane 1). Western blot
analysis further showed persistent MALT1 proteolysis in SSK41
cells generating the p76 (Figure 5D) and the p19 fragments (Figure
S2A). MALT1 protease activity could be further increased in
SSK41 cells via stable expression of an oncogenic Card11-L232LI
(C11m) mutant [50], yielding increased processing of MALT1 and
CYLD (Figure 5D, lane 4). Similarly, stable expression of the
API2-MALT1 fusion variants A7M3 and A7M8 (which result
from fusion of exon 7 of API2 with exon 3 or 8 of MALT1,
respectively) not only induced cleavage of the API2-MALT1-
specific substrate NIK [36], but it also increased the levels of
cleaved CYLD (Figure 5D, lane 2 and 3). Both NIK and CYLD
were more efficiently cleaved by the A7M3 variant than by A7M8,
suggesting that the Ig1-Ig2 domains somehow enhance the
protease activity of A7M3. We further noticed increased levels
of MALT1 p76 in SSK41-A7M3 cells in contrast to A7M8
expressing cells (Figure 5D, lane 2 and 3). The A7M3 fusion
contains the R149 cleavage site of MALT1, suggesting that A7M3
proteolysis might contribute to the increased p76 levels (Figure
S2B). Western blot analysis of lysates of 293T cells expressing
Figure 4. MALT1 p76 activates NF-kB signalling in 293T cells. A) Features of Flag-tagged MALT1, p76, MALT1-C and MALT1-p19. Numbers
indicate the start and stop AA position for p76, MALT1-C and MALT1-p19 relative to the MALT1 protein sequence (Refseq NP_006776.1, 824 AA). B-C)
NF-kB-reporter assays of 293T cells transiently expressing MALT1, mp-MALT1, MALT1-p19, p76 and mutants or MALT1-C. NF-kB-dependent luciferase
activity is shown as fold induction of vector-transfected cells and represents the mean +/- S.D. (n = 3). Immunoblot of cell lysates with a-Flag – a-b-
actin shows equal expression/loading of the different MALT1 constructs (B) and a-MALT1-C (C) shows equal expression of the different MALT1
constructs. Bottom (C): streptavidin pull-down (bio-IP) of MALT1, p76 or MALT1-C, transiently expressed in 293T cells, and immunoblotted with a-
MALT1C, a-TRAF6 and a-BCL10 antibodies. e-MALT1, e-TRAF6, e-BCL10: endogenous MALT1, TRAF6 and BCL10. D) immunoblot of bio-IPs of Avi-
tagged Ub-p76 expressed together with Flag-p76 or Flag MALT1 with a-MALT1-C, a-Flag and a-TRAF6. * indicate non-specific bands.
doi:10.1371/journal.pone.0103774.g004
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Figure 5. MALT1 auto-proteolysis in activated B cells. A) ABC-DLBCL cell lines HBL-1 and OCI-Ly3 were treated with 50 mM z-VRPR-fmk (36 hrs)
and lysates were analysed for the presence of MALT1 and BCL10 cleavage fragments with a-MALT1, a-Cleaved BCL10 and a-Tubulin (loading control).
B-C) The GCB-DLBCL cell lines BJAB and Raji were left untreated or stimulated with PMA/ionomycin (30 min) with or without pre-treatment with
50 mM z-VRPR-fmk (30 min). Lysates were analysed for the presence of MALT1 and BCL10 cleavage fragments, for p-ERK (activation control) and
tubulin (loading control). D) Immunoblot of lysates of SSK41 cells and SSK41 cells with ectopic expression of the API2-MALT1 fusion variants A7M3
MALT1 Auto-Proteolysis Triggers NF-kB Activation
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A7M3 indeed showed both the C-terminal p76 fragment and the
anticipated N-terminal fragment of 54 kDa, which were absent for
an A7M3-R149A mutant (Figure S2C). Again, the R149A
mutation did not affect the protease activity of A7M3 as cleavage
of A20 and CYLD were unaffected (Figure S2C). Altogether, these
data demonstrate that MALT1 undergoes auto-processing in
lymphoma cells as a consequence of either constitutive upstream
signals promoting MALT1 activation (such as in ABC DLBCL
expressing oncogenic CARMA1) or a genetic fusion of MALT1 to
the apoptosis inhibitor API2, which results in the formation of a
hyperactive oncogenic API2-MALT1 fusion protein.
MALT1 auto-proteolysis is required for optimal IL-2
production in Jurkat T cells
Next, we investigated whether MALT1 auto-processing affects
T-cell activation. Stimulation of Jurkat T cells induced MALT1
protease activity, as demonstrated by the appearance of cleaved
BCL10 after 30 minutes of P/I stimulation (Figure 6A). Simulta-
neously, the MALT1 p19 fragment was detected in lysates of these
cells, and both cleavage events could be prevented by treatment of
the cells with the MALT1 protease inhibitor z-VRPR-fmk
(Figure 6A). To assess the relevance of MALT1 cleavage in T-
cell activation, we generated Jurkat T cells that overexpress wild-
type MALT1, the cleavage insensitive R149A mutant, the
catalytically inactive C464A mutant or the double R149A/
C464A mutant (RACA). Stimulation of these cells with P/I
showed that none of the mutants affected the levels of inducible
phosphorylation of IkBa or JNK or the nuclear accumulation of
NF-kB subunits (Figure S4), events that are known to depend on
the scaffold function of MALT1. Moreover, and in contrast to the
C464A and RACA mutants, the R149A mutant did not affect
cleavage of the MALT1 substrates A20, CYLD or RELB (Figure
S4). Similar observations were made in the C464A and R149A
cells in which endogenous MALT1 was inactivated using TALENs
that target exon 2 of MALT1 (Figure S5 and S6).
Next, we tested the role of MALT1 auto-processing in the
expression of the NF-kB target gene IL-2. Compared to cells
expressing exogenous wild-type MALT1, the stimulation-induced
IL-2 secretion of the MALT1-R149A and -C464A mutant-
expressing cells was reduced by 85 and 75%, respectively,
indicating an important role for MALT1 cleavage at R149 in
the IL-2 production of activated Jurkat T cells (Figure 6B).
Nevertheless, all constructs showed comparable binding to BCL10
and TRAF6 (Figure 6C). Residual IL-2 production by Jurkat T
cells expressing MALT1-C464A or R149A might have resulted
from endogenous MALT1 that, upon stimulation, is able to cleave
the C464A mutant or is cleaved by the R149A mutant, thereby
generating the p76 fragment. Consistent with this hypothesis,
stable expression of the MALT1-RACA double mutant, which
excludes both possibilities, led to an almost complete inhibition of
IL-2 production by stimulated Jurkat T cells (Figure 6B),
suggesting that MALT1 auto-proteolysis might occur mainly in
trans. Collectively, these data point towards a unique role for
MALT1 auto-proteolysis and the resulting p76 fragment of
MALT1 in T-cell activation.
MALT1 auto-proteolysis is required to induce the
transcription of NF-kB target genes
So far, our data suggested that MALT1 auto-proteolysis affects
neither IKK activation nor the nuclear translocation of NF-kB,
despite a profound defect on the expression of the NF-kB target
gene IL-2. Bi-allelic inactivation of endogenous MALT1 in R149A
cells (JDM-RA) further reduced IL-2 as well as CSF2 secretion to
the basal levels observed in Jurkat T cells with bi-allelic MALT1
inactivation (JDM) (Figure 7A). To assess whether these defects in
IL-2 and CSF2 secretion were due to defects in transcription, we
performed qRT-PCR analysis. A stimulus-dependent up-regula-
tion of IL-2 and CSF2 mRNA levels was observed in the MALT1
expressing Jurkat T cells, while all Jurkat mutants were seriously
hampered in their mRNA up-regulation (Figure 7B). Next we
performed luciferase reporter assays with the different Jurkat
clones. Cells expressing wild-type MALT1 showed a stimulus-
dependent increase of gene reporter constructs containing the IL-2
promotor (IL-2p-Luc) or three NF-kB sites from the promoter of
the kappa light chain of immunoglobulin (Igk3-ConALuc), while
this response was strongly impaired in JDM-CA or JDM-RA cells
(Figure 7C). Together, these findings clearly support a role for
MALT1 auto-proteolysis in regulating NF-kB transcriptional
activity. To explore this further, we performed RNA sequencing
for stimulated Jurkat MALT1 cells and the mutant RACA, JDM-
CA and JDM-RA cells. Compared to the Jurkat MALT1 cells, the
three mutant cell lines showed between 79 and 278 differentially
expressed genes (DEGs) with a greater than two-fold change and a
false discovery rate (FDR) q,0.001 after 3 or 18 hrs of stimulation
with P/I (Table S2). qRT-PCR analysis performed for a selection
of top ranked genes confirmed the effects observed by RNA
sequencing (Table S3). Gene Set Enrichment Analysis (GSEA)
indicated a significant enrichment of NF-kB target genes (http://
www.bu.edu/nf-kb/gene-resources/target-genes) in the down-
regulated genes of the datasets for RACA, JDM-CA and JDM-
RA cells at 3 and 18 hrs of stimulation (FDR,0.001) (Figure 7D
and Table S4). Ingenuity Pathway Analysis (Ingenuity Systems)
linked the signatures of the RACA, JDM-CA and JDM-RA cells
with reduced activation/proliferation of lymphocytes and inhibi-
tion of NF-kB signalling (Table S5). Collectively, these data
demonstrate that MALT1 auto-processing is required to induce
optimal transcription of NF-kB target genes in activated Jurkat T
cells.
Discussion
Here, we provide several lines of evidence for an essential role of
MALT1 auto-proteolysis in NF-kB dependent gene transcription
in activated lymphocytes. First, activation of MALT1 induced its
proteolytic cleavage at R149 in 293T cells. Second, recombinant
MALT1 was able to cleave itself in vitro at R149. Third,
continuous MALT1 auto-proteolysis was observed in ABC-
DLBCL cells and SSK41 MALT lymphoma cells that have
constitutive MALT1 protease activity. Fourth, B- and T-cell
stimulation induced MALT1 cleavage. Finally, an un-cleavable
MALT1 mutant did not prevent initial IkBa phosphorylation and
nuclear accumulation of NF-kB subunits but impaired the
transcriptional activation of NF-kB target genes.
and A7M8, or the L232LI mutant of Card11 (C11m) respectively, with antibodies against the MALT1 C-terminus, the p76 neo-epitope, the CYLD C-
terminus, the NIK C-terminus and Flag (ectopic A7M3, A7M8 and C11m). Numbers below blots depict band intensities of MALT1, p76 and the CYLD
p70 fragment relative to lane 1. * = non-specific band. LC: loading control, a non-specific band obtained with the p76 neo-epitope antibody was
used.
doi:10.1371/journal.pone.0103774.g005
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TCR engagement induces the redistribution of BCL10 and
MALT1 to the membrane rafts at the TCR complex, which is
essential to activate NF-kB signalling [22,23,51]. Artificial
membrane anchoring of MALT1 not only activated its protease
activity and NF-kB signalling, but also induced MALT1 auto-
proteolysis. The resulting p76 cleavage product efficiently
oligomerized and activated NF-kB signalling in a TRAF6-
dependent manner. TRAF6 mediates K63-linked poly-ubiquitina-
tion of itself, MALT1 and IKKc which facilitates activation of the
IKK complex and phosphorylation of IkBa. This mechanism and
also the nuclear accumulation of the NF-kB subunits were
however not affected in MALT1-deficient Jurkat T cells expressing
un-cleavable MALT1 (JDM-RA), suggesting a role for MALT1
auto-proteolysis further downstream in regulating NF-kB tran-
scriptional activation. Interestingly, MALT1 was reported to
shuttle between the nucleus and cytoplasm and its nuclear
retention reduced NF-kB signalling [52], suggesting an inhibitory
function for MALT1 in the nucleus. Whether MALT1 auto-
proteolysis relieves this inhibitory potential on NF-kB signalling
will be an interesting aspect of future work.
MALT1 controls T- and B-cell activation via both its adaptor
and protease function. As an adaptor, MALT1 is required for
building up the proximal signalling complex that controls the
IKK-dependent activation of the canonical NF-kB pathway, as
well as the activation of the c-JUN N-terminal kinase (JNK)
dependent transcriptional pathway. The protease function of
MALT1 apparently serves to promote gene transcription by
inactivating negative regulators of NF-kB and JNK signalling, like
A20, RELB and CYLD. Moreover, MALT1-dependent cleavage
of the RNAse MCPIP1 (also known as Regnase-1) is thought to
lead to the stabilization of the resulting transcripts [35]. Auto-
processing of MALT1 did not affect these functions, since the
processing-deficient R149A mutant showed normal protease
activity and an unaltered capacity to promote IKK or JNK
activation. The data presented in this study therefore reveal a
highly interesting novel aspect of MALT1’s function, which is
controlled by the auto-proteolytic removal of the N-terminal death
domain and the BCL10 binding site. This results in the formation
of an active C-terminal p76 fragment of MALT1 that dissociates
from BCL10 and oligomerizes to promote NF-kB-dependent
transcription in a TRAF6-dependent manner. These findings
support a model in which the p76 fragment of MALT1, in
combination with TRAF6 and potentially additional components,
directly or indirectly affects the transcriptional activity of NF-kB
complexes by means that remain to be discovered (Figure 8).
In conclusion, our study identifies MALT1 auto-proteolysis as
essential for optimal NF-kB transcriptional activity in antigen
receptor signalling and further strengthens the position of MALT1
protease as an attractive target for immune-suppression.
Materials and Methods
Antibodies and plasmids
Primary antibodies used in this study included antibodies
specific for the Flag epitope (M2), b-Actin (A1978) and tubulin (B-
5–1-2) from Sigma-Aldrich, HA (12CA5) from Roche, A20
(ab45366) and MALT1-N (ab33921) from Abcam, BCL10 (sc-
5273 and sc-5611), TRAF6 (sc-7221), CYLD E10 (sc-74435), p65
(sc-372), p50 (sc-114), c-Rel/REL (sc-71), Lck (sc-433) and cJun-P
(sc-16312) from Santa Cruz Biotechnology, and P-IkB-a (Ser32/
36, 5A5), P-ERK (Thr202/Tyr204, #9101), P-p38 (#9211), P-
JNK (#9255), RelB (#4922) and NIK (#4994) from Cell
Signaling Technology and GAPDH (MAB374) from Millipore.
Anti-MALT1-C [5], anti-MALT1 [31] and anti-cleaved BCL10
[38] were reported previously. Anti-p76 is an affinity purified
rabbit polyclonal raised against a nonapeptide (ATGHPFVQY)
corresponding to the N-terminus of cleaved MALT1 p76
(Eurogentec).
Figure 6. MALT1 auto-proteolysis is required for IL-2 production by Jurkat T cells. A) Jurkat T cells were left untreated or stimulated with
P/I for 30 min, with or without pre-treatment with 50 mM z-VRPR-fmk for 30 min. Lysates were analysed for the presence of the cleavage fragments
for BCL10 and MALT1 p19, for p-ERK (activation control) and tubulin (loading control). B) IL-2 production (ELISA) of Jurkat T cells stably expressing
MALT1, MALT1-R149A, MALT1-C464A or MALT1-RACA, either untreated (-) or stimulated for 18 hrs with PMA/ionomycin (P/I). Data shown as mean +/-
S.D. (n = 3). Inset: Immunoblot with a-MALT1-C and a-Flag showing expression of ectopic MALT1 and mutants relative to endogenous MALT1 (lane 1).
Numbers indicate fold overexpression relative to endogenous MALT1. AS: a-specific band obtained with a-Flag that serves as loading control. C)
Immunoblot of cell lysates (top) and bio-IPs (bottom) from Jurkat T cells and Jurkat T cells with stable expression of Avi-tagged MALT1 or MALT1
mutants R149A, C464A and RACA with indicated antibodies.
doi:10.1371/journal.pone.0103774.g006
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All constructs for expressing proteins in eukaryotic cells were
made in pcDNA3.1 (Clonetech Laboratories) encoding an N-
terminal Flag- (with or without a StrepII-tag) or HA-epitope or in
pCR3 (InVitrogen, constructs used for Figure 2A). To direct raft
association of MALT1, the myristoylation/palmitoylation (mp)
motif of Lck (MGCVCSSNPEDD) was inserted in front of the
Flag epitope (pcD-mp-F-MALT1). Vectors enabling expression of
biotinylated proteins were described previously [45]. For expres-
sion of native p76, its coding sequence was cloned in frame with
HA-tagged ubiquitin at the N-terminus and the Avi-tag at the C-
terminus in pcDNA3.1.
Cell Culture
HEK293T (or 293T) (ATCC CRL-11268), HKB11 cells
(ATCC CRL-12568) and SSK41 ([53], kindly provided by Dr.
M Dyer) cells were cultured in DMEM-F12 (Life Technologies)
supplemented with 10% fetal calf serum (FCS). Jurkat T cells [54],
RAJI B cells (ATCC CCL-86) and the DLBCL cell lines BJAB
[55], HBL-1 [56] and OCI-Ly3 [57] were grown in RPMI
medium 1640 (Life technologies) supplemented with antibiotics
and 10% FCS (for Jurkat, RAJI, and BJAB) or 20% FCS (HBL-1
and OCI-Ly3). Jurkat T cells with stable expression of MALT1,
MALT1-C464A, MALT1-R149A or the double mutant MALT1-
RACA were generated as described [30].
For stimulation of cells, a mixture of PMA (phorbol 12-
myristate 13-acetate; 10-50 ng/ml; Alexis Biochemicals) and
ionomycin (1 mM; Calbiochem) was used. In some experiments,
cells were pre-incubated with 50 mM z-VRPR-fmk (Bachem AG)
for 30 min before stimulation with PMA and ionomycin. DLBCL
cell lines and SSK41 MALT1 lymphoma cells were treated with z-
VRPR-fmk or z-LVSR-fmk (Bachem AG) for 36 hrs.
MALT1 in vitro assay
HKB11 cells were transfected (TurboFect, Fermentas) with a
linearized expression construct for Flag-StrepII-tag-MALT1 (F-
STII-MALT1) in a pcDNA3.1-puro vector and clones with stable
expression were obtained after limiting dilution. Clones with high
expression were adapted for high-density suspension culture in 293
serum free medium II (293 SFM II, Life Technologies).
Recombinant MALT1 was purified using Strep-Tactin Superflow
Figure 7. MALT1 auto-proteolysis is required for NF-kB transcriptional activity in Jurkat T cells. A) Relative IL-2 and CSF2 production of
indicated Jurkat T cell lines, stimulated for 18 hrs with PMA/ionomycin, measured via ELISA. Data shown as mean +/- S.D. (n = 3). B) Jurkat T cells
expressing MALT1 and the JDM-CA, JDM-RA, and JDM cells were stimulated for the indicated times with P/I and IL-2 and CSF2 transcript levels were
determined via qRT-PCR. C) Jurkat T cells with ectopic expression of MALT1 and JDM-CA, JDM-RA and JDM were electroporated (Amaxa,
Nucleofection) with Luciferase reporter constructs driven by the IL-2 promoter or the Igk3-ConA promoter, and 24 hrs later stimulated with P/I for
18 hrs before Luciferase activity was measured. Data shown as mean +/- S.D. (n = 3). D) GSEA showing a significant enrichment of NF-kB-target genes
(FDR q,0,001) in the pre-ranked down-regulated genes from JDM-CA, JDM-RA and RACA cells stimulated for 18 hrs with P/I. Gene list depicted at the
right side are NF-kB target genes down-regulated in JDM-CA, JDM-RA and RACA cells after 3 and 18 hrs stimulation with P/I.
doi:10.1371/journal.pone.0103774.g007
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resin according to the manufacturer’s protocol (IBA). Purified F-
STII-MALT1 (1 mg) was incubated at 37uC for 2 h in a total
volume of 25 ml paracaspase assay buffer (50 mM MES, pH 6.8,
150 mM NaCl, 10% (wt/vol) sucrose, 0.1% (wt/vol) CHAPS (3-
[(3-cholamidopropyl)-dimethylammonio]-1-propane sulfonate hy-
drate), 10 mM dithiothreitol and 0.2, 0.4, 0.6 or 0.8 M NH4-
citrate respectively, with or without MALT1 protease inhibitors z-
VRPR-fmk (Bachem AG) and z-LVSR-fmk (Bachem AG). An
aliquot of the reactions was diluted in (1/100) in paracaspase assay
buffer containing 50 mM Ac-LVSR-AMC (Genecust) to measure
MALT1 protease activity. 25 ml reactions in 384-well black plates
(Greiner Bio One) were measured with excitation/emission
wavelengths of 390/460 in a plate reader (BMG Labtech).
Both wild-type human MALT1 (S2-K824) and a protease
inactivated MALT1 (S2-K824) with a C464A mutation was fused
with the leucine-zipper sequence from GCN4 (251–281) in the N-
terminus (LZ-MALT1) as described [47]. On the N-terminal
preceding the LZ-tag an Avi-tag and a 6xHisAsn-tag was added to
the constructs that was cloned into pFastBac1, followed by virus
generation and protein expression in S. frugiperda (Sf21) [58]. LZ-
MALT1 was purified by Ni-NTA affinity chromatography
(Qiagen) followed by gel filtration chromatography on a Superdex
200 16/60 (GE Healthcare) in buffer containing 25 mM Tris-Cl
(pH 7.5), 150 mM NaCl, 10% (w/v) glycerol and 1 mM TCEP.
MALT1 protease in vitro reactions were performed as described
for F-STII-MALT1.
FRET-based and Western blot analysis of MALT1 protease
activity
FRET-based determination of MALT1 activity in 293T cells
was essentially done as described (41). In brief, cells were
transfected with the eYFP–Leu-Val-Ser-Arg–eCFP reporter con-
struct, together with indicated combinations of MALT1 and
BCL10 expression constructs. 24 h after transfection, cells were
resuspended in flow cytometry buffer (1% FCS and 1 mM EDTA
in PBS) and analyzed with an LSR II (BD Biosciences) containing
405-, 488-, 561- and 640-nm lasers. To measure the eCFP and
FRET signal, the transfected cells were excited with a standard
450/50 filter for collection of the eCFP fluorescence and a 585/42
filter for FRET fluorescence, respectively, and for each sample at
least 5,000 highly eYFP+ cells were counted (41). In parallel to
flow cytometry, cell lysates were assessed for eYFP–Leu-Val-Ser-
Arg–eCFP reporter cleavage by Western blot using anti-GFP
(ALX 210-199; Enzo LifeSciences).
TALEN-mediated targeted disruption of MALT1 in Jurkat
T cells
TALENs that target a BfaI site (ttctttctgttgctttcAGTTGCCTA-
GACCTGgagcagtgttctcttaa) in the 59 end of exon2 of MALT1
were constructed by Cellectis. Jurkat clones expressing MALT1-
C464A and MALT1-R149A were electroporated as above with
the TALENs followed by single cell dilution and expansion in 96
well plates. Cells were lysed in 400mM KOH/100mMDTT for 59
at 4uC, sample was freeze/thawed (2X), the lysate was neutralized
with an equal volume of 400mM HCL/600mM Tris pH7.5, and
then used directly for PCR amplification (primers in Table S1).
PCR products for MALT1 intron1-exon2 were digested with BfaI
to identify clones with a deletion/mutation in exon2, which were
confirmed by sequencing individual cloned PCR fragments
(pGEM-T-easy, Promega). The procedure was repeated to
inactivate and confirm deletion of the second MALT1 allele. Bi-
allelic MALT1 inactivation was confirmed for two clones of
MALT1-C464A (JDM –CA1 and -CA2) and two of MALT1-
R149A (JDM –RA1 and -RA2) by sequence analysis of larger PCR
fragments that contain a SNP located 489 bp upstream of exon 2
of MALT1 (Figure S6). The same procedure was applied to
generate Jurkat T cells deficient for MALT1 (JDM).
Western Blot Analysis, bio-IPs and purification of
Detergent Resistant Membrane (DRM) fractions
For some experiments (Figures 5A/B/C and 6A), cells were
lysed in ice-cold HEPES-NaCl lysis buffer (50 mM HEPES,
pH 7.4, 150 mM NaCl, and 1% Triton X-100) complemented
with inhibitors of proteases (0.2 mg/mL AEBSF, 2 mg/mL
aprotinin, and 10 mg/mL leupeptin) and phosphatases (50 mM
NaF, 10 mM Na4P2O7, and 10 mM NaVO4). Postnuclear cell
lysates were boiled with reducing SDS sample buffer and analysed
by SDS-PAGE on 15% gels.
Avi-tagged proteins become biotinylated in eukaryotic cells via
co-expression of the E. coli BirA biotin protein ligase [59]. After
washing with PBS, cells were lysed for 30 min on ice in non-
Figure 8. Model for MALT1 functions in TCR-mediated NF-kB1
activation. A) The adaptor function of MALT1 is required for TCR-
mediated activation of the IKK complex. Via formation of the CARMA1/
BCL10/MALT1 complex MALT1 controls TRAF6-mediated K63 poly-
ubiquitination of the gamma subunit of the IKK complex. Concurrent
phosphorylation of IKKb activates the IKK complex that phosphorylates
the NF-kB inhibitor IkB, induces its proteasomal degradation and allows
nuclear translocation of NF-kB complexes consisting of p50, p65 and
REL. B) Parallel induction of MALT1 protease activity prevents de-
ubiquitination of IKKc and possibly other substrates via A20 cleavage
and facilitates DNA binding of p65- or REL-containing NF-kB complexes
via RELB cleavage. C) MALT1 auto-proteolysis represents a third level of
MALT1 regulation that controls in a TRAF6-dependent and BCL10-
independent manner the transcriptional activation of nuclear NF-kB
complexes via a yet unknown mechanism.
doi:10.1371/journal.pone.0103774.g008
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denaturing lysis buffer (NDLB: 20 mM Tris-Cl pH 7,6, 110 mM
NaCl, 2 mM EDTA, 0,3% NP-40 and 10% glycerol, Supple-
mented with phosphatase inhibitors (30 mM NaF, 1 mM
Na3VO4, 2 mM Na2MoO4, 5 mM Na4P2O7) and 1X Complete
protease inhibitor cocktail (Roche). The biotinylated protein
complex is precipitated using paramagnetic streptavidin beads
(Dynabeads M-280, Invitrogen) for 1 hour at 4uC. Protein
precipitates were washed four times in lysis buffer and boiled for
10 min with reducing SDS sample buffer. All samples were size
separated on 4-12% SDS-polyacrylamide gels (NuPage, Invitro-
gen) and transferred to polyvinylidene difluoride membranes (GE
Healthcare) for detection. Lipid raft purifications were performed
as described previously [5].
NF-kB Reporter Assays, ELISA and FRET assay
NF-kB reporter assays in 293T cells were performed as
described [5]. Nucleofection of Jurkat T cells was performed
according to the manufacturer’s recommendations (Amaxa Cell
Line Nucleofector Kit V, Lonza AG). IL-2 and CSF2 in the
supernatant of the different Jurkat clones, unstimulated or
stimulated for 18 hrs with 75 ng/ml PMA – 150 ng/ml
ionomycin, was measured by ELISA (OptEIA hIL-2 ELISA kit,
BD Pharmingen) according to the manufacturer’s protocol. For
the cellular MALT1 protease assay, HEK293T cells were
transfected the eYFP–LVSR–eCFP probe and MALT1/BCL10
constructs, and analysed by flow cytometry for gain of eCFP
fluorescence as described [41].
Quantitative RT-PCR and RNA sequencing
RNA isolation and cDNA synthesis were performed using
standard protocols. Quantitative RT-PCR was performed with the
LightCycler 480 SYBR Green I master mix (Roche Diagnostics)
and analyzed using the comparative dCt method using HPRT1 as
a reference control. Primer sequences are shown in the Table S1.
For RNA sequencing, the libraries were prepared according to
the standard Illumina TruSeq RNA sample preparation protocol
(Illumina). RNAseq libraries were constructed for Jurkat T cells
expressing MALT1 (2X), MALT1 RACA (2X) and for JDM-CA1,
JDM-CA2, JDM-RA1, JDM-RA2 (each 1X), and this un-
stimulated or after stimulation with 75 ng/ml PMA – 150 ng/
ml ionomycin for 3 and 18 hrs respectively. Each library was
sequenced on an Illumina HISeq 2000 according to the
manufacturer’s recommendations generating single-end 50 bp
reads. Differential gene expression between RNA-sequencing
datasets was analyzed using TopHat and Cufflinks as described
(Trapnell et al., 2012), using JDM-CA1/JDM-CA2 and JDM-
RA1/JDM-RA2 as experimental repeats. The RNA sequencing
data have been submitted to the GEO database and assigned the
accession number GSE52934.
Functional and pathway analysis of RNAseq data
Ingenuity Pathway Analysis (Ingenuity Systems) was used for
biological knowledge mining. Enrichment tests with a gene set for
NF-kB targets (http://www.bu.edu/nf-kb/gene-resources/target-
genes) was carried out using the Gene Set Enrichment Analysis
(GSEA) software. The q values for each gene-set were calculated
by using 1000 permutations and a False Discovery Rate ,25%.
Supporting Information
Figure S1 MALT1 cleavage does not affect its protease
activity. A) Immunoblot of lysates of 293T cells transiently
expressing mp-MALT1 and its mutants as specified with a-
MALT1-N. eMALT1: endogenous MALT1. Arrow indicates the
N-terminal p19 cleavage fragment. All molecular mass standards
are in kDa. B) Immunoblot of lysates of 293T cells transiently
expressing mp-MALT1, its R149A and C464A mutants, and
Ubiquitin-p76 with indicated antibodies. Arrows indicate the
MALT1 (p76), CYLD (p70) and A20 (p50) cleavage fragments
respectively. * non-specific fragments. LC: a-specific fragment
detected with the p76 neo-epitope antibody used as loading
control. C) HEK293T cells were transfected with the eYFP–Leu-
Val-Ser-Arg–eCFP probe (eYFP-LVSR-eCFP) and the indicated
constructs. Probe cleavage (as gain in eCFP fluorescence, labeled
as ‘‘% of fluorescent cells with FRET loss’’ in the y-axis of the
graph) was assessed by flow cytometry, gating on eYFPhi cells
(upper panel). In addition, cell lysates were analyzed by blotting
for MALT1, BCL10, GFP and Tubulin, as indicated (lower panel).
Compared to flow cytometry, in which only eYFPhi cells are
included in the analysis, the Western blot analysis shows a higher
percentage of reporter cleavage because all cells (including cells
expressing low levels of the reporter) are lysed and analyzed.
(TIF)
Figure S2 MALT1 and API2-MALT1 autoproteolysis in
SSK41 lymphoma cells. A) Immunoblot of lysates from SSK41
cells, left untreated or treated with 50 mM z-VRPR-fmk (36h),
with antibodies against MALT1, cleaved BCL10 and tubulin.
Arrow indicates the MALT1 p19 cleavage fragment. B) Features
of the A7M3 fusion variant of API2-MALT1 plus the domain
content (solid bars) of the 53 and 76 kDa cleavage fragments. BIR:
Baculovirus ‘‘inhibition of apoptosis’’ repeat. C) Immunoblot
analysis of lysates of 293T cells transiently expressing increasing
concentrations of Flag-tagged A7M3 and A7M3-R149A mutant,
indicating the p76 C-terminal fragment detected with a-MALT1-
C (left) or the p76 neo-epitope specific antibody (middle). Right:
Immunoblot analysis of 293T cells transiently expressing the
API2-MALT1 fusion variant A7M3, A7M3-R149A and A7M3-
C464A with antibodies against CYLD and A20. Arrows indicate
their respective p70 and p50 cleavage fragments. Immunoblot
with the Flag antibody (N-terminus) was performed to demon-
strate equal expression of A7M3 or its mutants and shows the N-
terminal cleavage fragment (p54) of A7M3. * non-specific
fragment.
(TIF)
Figure S3 MALT1 undergoes auto-proteolysis in vitro.
Top: In vitro cleavage of the fluorogenic tetrapeptide substrate Ac-
LVSR-AMC (50 mM) by F-STII-MALT1 in increasing concen-
trations of the cosmotropic salt NH4-citrate (0.2, 0.4, 0.6, and
0.8 M). The barchart shows cleavage activity as Fluorescence
Units (FU) increase/min. Results are expressed as means 6 SD
(n= 3). Bottom: enzymatic reactions were analysed by immuno-
blotting with a-MALT1-N. The blot was previously cut in two to
detect p76 and p19 separately, which explains the white line in the
middle.
(TIF)
Figure S4 MALT1 auto-proteolysis is not required for
initial IkBa phosphorylation and NF-kB nuclear translo-
cation in Jurkat T cells overexpressing MALT1 mutants.
Jurkat T cells expressing MALT1 or the mutants C464A, R149A
and RACA were stimulated with P/I for indicated times and
cytosolic and nuclear extracts were immunoblotted with indicated
antibodies. Blots used to detect c-Rel were re-used without
stripping to detect RELB and therefore both bands are visible in
the RELB panel (upper band = c-Rel, lower band = RELB).
(TIF)
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Figure S5 MALT1 auto-proteolysis is not required for
initial IkBa phosphorylation and NF-kB nuclear translo-
cation in JDM-CA and JDM-RA cells. A) Jurkat T cells
expressing MALT1-C464A or MALT1-R149A were genetically
modified with TALENs to inactivate endogenous MALT1
expression generating JDM-CA and JDM-RA cells respectively.
Cells were stimulated with P/I for indicated times and cytosolic
and nuclear extracts were immunoblotted with indicated antibod-
ies. LC: a-specific band used as loading control. B) JDM-CA and
JDM-RA cells were pre-treated with MG-132 for 30 min before
stimulation for 15 or 30 min with PMA/ionomycin (P/I). Total
cell lysates were immunoblotted with indicated antibodies. LC: a-
specific band used as loading control. C) Immunoblot with a-
MALT1-N showing expression of ectopic MALT1 and mutants
relative to endogenous MALT1 (lane 5) in the different Jurkat cell
lines. b-actin: loading control.
(TIF)
Figure S6 TALEN-mediated knock-out of endogenous
MALT1. Jurkat T cells and Jurkat T cells with ectopic expression
of MALT1-R149A and MALT1-C464A were electroporated with
TALEN pairs targeting a BfaI at the intron1-exon2 boundary of
MALT1. Position and size of the introduced deletions in the
different generated cell lines are indicated. A single nucleotide
polymorphism located 489 bp upstream of exon 2 of MALT1 was
used to discriminate the 2 MALT1 alleles.
(TIF)
Table S1 Sequences of primer pairs used for qRT-PCR
analysis.
(XLSX)
Table S2 Differentially expressed genes at 3 and 18 hrs
of stimulation with PMA/Ionomycin in JDM-CA, JDM-RA
and RACA vs MALT1 expressing cells with more than 2
fold change and FDR q,0,001.
(XLSX)
Table S3 qRT-PCR validation of differentially ex-
pressed genes between MALT1 and JDM-CA, JDM-RA
and RACA respectively at 3 and 18 hrs of stimulation
with PMA/Ionomycin.
(XLSX)
Table S4 Gene set enrichment analysis of NF-kB target
genes (Boston) in the pre-ranked sets of ‘‘differentially
expressed genes’’ for JDM-CA, JDM-RA and RACA at 3
and 18 hrs of stimulation with P/I.
(XLSX)
Table S5 Ingenuity Pathway analysis of differential
expression of JDM-CA, JDM-RA and RACA cells.
(XLSX)
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